Researchers from Vanderbilt University School of Medicine and Baylor College of Medicine have developed a new method for stable, long-term delivery of therapeutic proteins using antigen-specific T cells whose genomes have been modified with a...

University of California, Los Angeles researchers have treated glioblastoma in mice by inhibiting epithelial membrane protein 2 . 1 The findings open up a new indication for spinout Paganini Biopharma Inc. , which has a mAb against...

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Cancer Cancer TEK tyrosine kinase, endothelial (TEK; Tie2) Studies in mice suggest that tumor-targeting cell-based delivery of interferon-a (IFN-a) could offer...

Neuropeptide hormones associated with pleasure and analgesia may have an unexpected role in fighting prostate cancer, according to a report in the Proceedings of the National Academy of Sciences . 1 The study ties together a...

Cell Based Delivery Inc. , Providence, R.I. Business: Hematology, Musculoskeletal Hired: Thomas Mathers as president, CEO and a director, formerly VP and general manager of Cardion Pharmaceuticals Inc. WIR Staff...

Cell Based Delivery (Providence, R.I.), a developer of implantable protein delivery systems for hematology, musculoskeletal disorders hired Thomas Mathers as president, CEO and a director. Prior, he was VP and general manager of Cardion . BC...